- Home
- DCTH vs RMM Comparison
DCTH vs RMM Comparison
Compare DCTH & RMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- RMM
- Stock Information
- Founded
- DCTH 1988
- RMM 2019
- Country
- DCTH United States
- RMM United States
- Employees
- DCTH N/A
- RMM N/A
- Industry
- DCTH Medical/Dental Instruments
- RMM Trusts Except Educational Religious and Charitable
- Sector
- DCTH Health Care
- RMM Finance
- Exchange
- DCTH Nasdaq
- RMM Nasdaq
- Market Cap
- DCTH 630.4M
- RMM 271.2M
- IPO Year
- DCTH N/A
- RMM N/A
- Fundamental
- Price
- DCTH $12.76
- RMM $13.50
- Analyst Decision
- DCTH Strong Buy
- RMM
- Analyst Count
- DCTH 4
- RMM 0
- Target Price
- DCTH $24.00
- RMM N/A
- AVG Volume (30 Days)
- DCTH 748.0K
- RMM 66.5K
- Earning Date
- DCTH 08-04-2025
- RMM 01-01-0001
- Dividend Yield
- DCTH N/A
- RMM 7.33%
- EPS Growth
- DCTH N/A
- RMM N/A
- EPS
- DCTH N/A
- RMM 0.96
- Revenue
- DCTH $53,850,000.00
- RMM N/A
- Revenue This Year
- DCTH $155.42
- RMM N/A
- Revenue Next Year
- DCTH $37.93
- RMM N/A
- P/E Ratio
- DCTH N/A
- RMM $15.55
- Revenue Growth
- DCTH 1068.87
- RMM N/A
- 52 Week Low
- DCTH $7.17
- RMM $12.32
- 52 Week High
- DCTH $18.23
- RMM $16.10
- Technical
- Relative Strength Index (RSI)
- DCTH 32.99
- RMM 42.00
- Support Level
- DCTH $13.30
- RMM $13.28
- Resistance Level
- DCTH $14.15
- RMM $13.49
- Average True Range (ATR)
- DCTH 0.66
- RMM 0.11
- MACD
- DCTH -0.27
- RMM 0.00
- Stochastic Oscillator
- DCTH 2.91
- RMM 37.15
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About RMM RiverNorth Managed Duration Municipal Income Fund Inc.
RiverNorth Managed Duration Muni Inc Fd is a United States based diversified, closed-end management investment company. Its primary investment objective is current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.